Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
270 USD | +0.22% | +0.39% | -6.26% |
26/04 | Amgen to Submit Thyroid Eye Disease Treatment Marketing Authorization Application in Europe | MT |
26/04 | Amgen to Seek European OK of Thyroid Eye Disease Drug Tepezza | DJ |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- AMGN Stock
- Revisions Amgen Inc.